Inflammatory Diseases Clinical Trial
Official title:
A Phase 1, Open-label, Sequential-group, Single-dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of AMG 592 Administered Subcutaneously in Healthy Chinese, Japanese, and Caucasian Subjects
The primary objective of this study is to evaluate the pharmacokinetics (PK) of efavaleukin alfa after single subcutaneous (SC) administration in healthy Chinese, Japanese, and Caucasian participants.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05656378 -
A Repository to Study Host-Microbiome Interactions in Health and Disease
|
||
Completed |
NCT00734240 -
Safety and Tolerability of Single and Multiple Doses of ISIS 353512 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT03044873 -
Effect of BMS-986165 on the Pharmacokinetics of Rosuvastatin
|
Phase 1 | |
Terminated |
NCT01364389 -
A 3-arm Proof of Concept Study of AIN457, ACZ885 or Corticosteroids in Patients With Polymyalgia Rheumatica
|
Phase 2 | |
Recruiting |
NCT06065592 -
Exploring Cancer-Associated Thromboembolism Prognosis Biomarkers and Polymorphisms
|
Phase 1 | |
Recruiting |
NCT05662033 -
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics (PK) of Oral AZD6793 in Healthy Subjects and to Assess the Relative Oral Bioavailability Between Two Formulations. The Study Will Also Assess the Food Effect on the PK of AZD6793 Compared to Fasting State
|
Phase 1 | |
Active, not recruiting |
NCT01981785 -
Investigation of Immune Disorders and Deficiencies
|
N/A |